Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Plant-based, non-dairy milk producers scored a win when the Food and Drug Administration issued guidance stating products like almond, oat, and soy options can be called milk.
Most Americans are worried about their finances, according to a survey. Kimberly Palmer, personal finance expert at NerdWallet, joined Cheddar News to help put Americans at ease about their spending.